Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Golembo

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Drug Targets|June 21, 2003
Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia--genetic short limbed dwarfismDavid Aviezer, Myriam Golembo, Avner Yayon
Molecular Genetics and Metabolism|March 18, 2014
Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technologyGregory A Grabowski, Myriam Golembo, Yoseph Shaaltiel
Bioscience Reports|August 29, 2013
Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systemsYoram Tekoah, Salit Tzaban, Tali Kizhner, et al.
Nature Communications|June 5, 2023
Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitisMasataka Ichikawa, Nobuhiro Nakamoto, Sharon Kredo-Russo, et al.
Nature Communications|July 2, 2025
Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trialIddo Weiner, Maya Kahan-Hanum, Nufar Buchstab, et al.
Cell|August 5, 2022
Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammationSara Federici, Sharon Kredo-Russo, Rafael Valdés-Mas, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Drug Targets|June 21, 2003
Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia--genetic short limbed dwarfismDavid Aviezer, Myriam Golembo, Avner Yayon
Molecular Genetics and Metabolism|March 18, 2014
Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technologyGregory A Grabowski, Myriam Golembo, Yoseph Shaaltiel
Bioscience Reports|August 29, 2013
Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systemsYoram Tekoah, Salit Tzaban, Tali Kizhner, et al.
Nature Communications|June 5, 2023
Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitisMasataka Ichikawa, Nobuhiro Nakamoto, Sharon Kredo-Russo, et al.
Nature Communications|July 2, 2025
Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trialIddo Weiner, Maya Kahan-Hanum, Nufar Buchstab, et al.
Cell|August 5, 2022
Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammationSara Federici, Sharon Kredo-Russo, Rafael Valdés-Mas, et al.
Pageof 1